SUSAN LATTANZI: Open Payments
NPI 1093963175 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 27 payments from 8 companies in 2025. Trend: 2023 $653 · 2024 $467 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $255 |
| E.R. Squibb & Sons, L.L.C. | 4 | $110 |
| Abbott Laboratories | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Medtronic, Inc. | 2 | $36 |
| BridgeBio Pharma, Inc. | 1 | $32 |
| Boston Scientific Corporation | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: ELIQUIS, VYNDAQEL, AVEIR, LEQVIO, CAMZYOS, Attruby, ACCOLADE SR, MICRA.
Industry payments across MA — which companies pay providers there.
